XML 46 R31.htm IDEA: XBRL DOCUMENT
v3.3.1.900

Business Restructuring and Asset Impairments | 12 Months Ended
--- | ---
Dec. 31, 2015
Restructuring And Related Activities [Abstract] |
Business Restructuring and Asset Impairments | 22. Business Restructuring and Asset Impairments 2014 Restructuring In the fourth quarter of 2014, a restructuring plan was approved that affected certain Company functions, principally the research and development function and to a lesser extent product safety and compliance and plant site accounting functions (primarily impacting the Surfactants reportable segment). The objective of the plan was to better align staffing resources with the needs of the Company’s diversification and growth initiatives. In implementing the plan, management offered a voluntary retirement incentive to employees of the affected functions. By December 31, 2014, 13 employees accepted the voluntary termination incentive. As a result, the Company recognized a $1,722,000 charge against income for the three and twelve months ended December 31, 2014. The restructuring was not considered a cost savings initiative but rather an opportunity to create some staffing flexibility to reposition roles to meet changing business needs. The severance payouts were completed by June 30, 2015. Other costs for the restructuring were not material. The following is a reconciliation of the beginning and ending balances of the restructuring liability:
(In thousands) |  | Severance Expense |
Restructuring liability at December 31, 2014 |  | $ | 1,722 |
Amounts paid |  |  | (1,695 | )
Foreign currency translation |  |  | (18 | )
Expense adjustment |  |  | (9 | )
Restructuring liability at December 31, 2015 |  | $ | — |
2014 Asset Impairments In the fourth quarter of 2014, the Company wrote off the net book values of three assets, resulting in a pretax charge against income of $2,287,000 for the three and twelve months ended December 31, 2014. All three assets were part of the Company’s Surfactants segment, although the write-off charges were excluded from Surfactants segment operating results. At the Company’s Singapore location, $1,316,000 of engineering costs for an asset expansion project were reversed out of the Company’s construction-in-process account and into expense because management determined that, given the business environment at that time, the magnitude of the project could no longer be economically justified. At the Company’s Millsdale, Illinois, plant, a reactor used to manufacture certain surfactant products was no longer required and was retired and removed from service. The book value of the asset was $714,000. The remaining $257,000 of impairment charges related to an administrative building at the Company’s United Kingdom site that was vacated and abandoned in place. 2013 Restructuring In the fourth quarter of 2013, the Company recorded a $1,040,000 restructuring charge for estimated severance expense related to an approved plan to reduce costs and increase operating efficiencies by consolidating a portion of the Surfactants segment’s North American manufacturing operations. In the third quarter of 2014, the Company shut down certain production areas at its Canadian manufacturing site, moving production in those areas to U.S. plants. This consolidation resulted in the elimination of 16 North American positions. Other restructuring costs for this plan were not material. The following is a reconciliation of the beginning and ending balances of the restructuring liability:
(In thousands) |  | Severance Expense |
Restructuring liability at December 31, 2013 |  | $ | 1,040 |
Amounts paid |  |  | (420 | )
Foreign currency translation |  |  | (57 | )
Restructuring liability at December 31, 2014 |  | $ | 563 |
Amounts paid |  |  | (464 | )
Foreign currency translation |  |  | (42 | )
Restructuring liability at December 31, 2015 |  | $ | 57 |
In connection with the planned business restructuring, the Company reduced the useful lives of the manufacturing assets in the affected areas of the Canadian plant. The change in useful lives resulted in accelerated depreciation expenses of $1,825,000 in 2014 and $296,000 in 2013. The depreciation expense was included in the cost of sales line of the consolidated statements of income for the years ended December 31, 2014 and 2013, respectively.

X
- References No definition available. + Details
Name: | us-gaap_RestructuringAndRelatedActivitiesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets. + References No definition available. + Details
Name: | us-gaap_RestructuringImpairmentAndOtherActivitiesDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration